This work is licensed under a Creative Commons Attribution 4.0 International License.
SEQ ID NO: 321 of Patent CN110785183A
General Information
DCTPep ID DCTPep06604
Peptide Name SEQ ID NO: 321 of Patent CN110785183A
Sequence AEMLESVIKNY
Sequence Length 11
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Cancer targeted peptides Immunotherapeutic peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target HLA-B*44
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C57H93N13O19S1
Absent amino acids CDFGHPQRTW
Theoretical pI 4.53
Acidic residues 2
Basic residues 1
Polar residues 3
Molecular weight (Average) 1296.5
Molecular weight (Monoisotopic) 1295.64
Common amino acids E
Net charge -1
Instability index (II) 18.88
Aliphatic index 106.36
Grand average of hydropathicity (GRAVY) -0.027
Half Life
4.4 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 1490
Abs 0.1% (=1 g/l) 1.149
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN110785183A
Patent Title Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.